Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ting Deng

Showing results (541-550 of 549) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 549 results.
Cancer Communications (London, England)|October 2, 2025
Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trialsJian Li, Ting Deng, Yanhong Gu, et al.
Cancer Communications (London, England)|October 19, 2021
Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II studyZhi Peng, Tianshu Liu, Jia Wei, et al.
Cancer Immunology, Immunotherapy : CII|July 5, 2024
Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancersZhenghang Wang, Siyuan Cheng, Yanhong Yao, et al.
Cell Reports. Medicine|December 5, 2024
Interpretable multi-modal artificial intelligence model for predicting gastric cancer response to neoadjuvant chemotherapyPeng Gao, Qiong Xiao, Hui Tan, et al.
Nature Medicine|July 16, 2025
CLDN18.2-targeting antibody-drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trialJia Liu, Jianwei Yang, Yuping Sun, et al.
Cancer|March 22, 2024
A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional studyMeiting Chen, Lu Li, Qing Xia, et al.
Nature Medicine|June 1, 2026
Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trialZhi Peng, Tianshu Liu, Hua Wang, et al.
Nature Human Behaviour|October 19, 2023
Genetic architectures of cerebral ventricles and their overlap with neuropsychiatric traitsYi-Jun Ge, Bang-Sheng Wu, Yi Zhang, et al.
JCO Precision Oncology|March 30, 2023
PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective StudyMifen Chen, Zhenghang Wang, Zimin Liu, et al.
Pageof 55

Showing results (541-550 of 549) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 549 results.
Cancer Communications (London, England)|October 2, 2025
Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trialsJian Li, Ting Deng, Yanhong Gu, et al.
Cancer Communications (London, England)|October 19, 2021
Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II studyZhi Peng, Tianshu Liu, Jia Wei, et al.
Cancer Immunology, Immunotherapy : CII|July 5, 2024
Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancersZhenghang Wang, Siyuan Cheng, Yanhong Yao, et al.
Cell Reports. Medicine|December 5, 2024
Interpretable multi-modal artificial intelligence model for predicting gastric cancer response to neoadjuvant chemotherapyPeng Gao, Qiong Xiao, Hui Tan, et al.
Nature Medicine|July 16, 2025
CLDN18.2-targeting antibody-drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trialJia Liu, Jianwei Yang, Yuping Sun, et al.
Cancer|March 22, 2024
A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional studyMeiting Chen, Lu Li, Qing Xia, et al.
Nature Medicine|June 1, 2026
Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trialZhi Peng, Tianshu Liu, Hua Wang, et al.
Nature Human Behaviour|October 19, 2023
Genetic architectures of cerebral ventricles and their overlap with neuropsychiatric traitsYi-Jun Ge, Bang-Sheng Wu, Yi Zhang, et al.
JCO Precision Oncology|March 30, 2023
PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective StudyMifen Chen, Zhenghang Wang, Zimin Liu, et al.
Pageof 55